Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?

Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?

Source: 
Motley Fool
snippet: 
  • Bloomberg reported that Bristol Myers Squibb wants to buy Aurinia.
  • A smaller deal appears to be what Bristol wants and could be a good move for the drugmaker.
  • Targeting small, cancer-focused biotechs might be an even better strategy for Bristol.